JASON STABACK: Open Payments
NPI 1750331948 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 34 payments from 11 companies in 2025. Trend: 2023 $265 · 2024 $785 · 2025 $658
Food & beverage: $589Education: $69
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $173 |
| PFIZER INC. | 7 | $114 |
| Janssen Biotech, Inc. | 1 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Incyte Corporation | 3 | $51 |
| Galderma Laboratories, L.P. | 3 | $50 |
| ABBVIE INC. | 3 | $48 |
| Lilly USA, LLC | 2 | $41 |
| GENZYME CORPORATION | 2 | $31 |
| Amgen Inc. | 1 | $16 |
Products named: CIBINQO, Rhapsido, COSENTYX, TREMFYA, DUPIXENT, OPZELURA, NEMLUVIO, SKYRIZI.
Industry payments across DE — which companies pay providers there.
